Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:
“How do we predict recurrence post Left Ventricular Thrombus ( LVT ) resoultion?
Echo at the time of LVT resolution preditctive than the time of Diagnosis
After LVT resolution, patient with left ventricular aneurysm (LVA) remained at high risk of recurrence regardless of anticoagulation status, with recurrence rates approaching 50–70% (Figure 1).
Stopping oral anticoagulation (OAC) after LVT resolution increased recurrence risk even in patients without LVA, rising to 19%(Figure 2).
Risk stratification combining LVA status and OAC use revealed a clear gradient of recurrence risk (Figure 3):
Without LVA and receiving OAC: 5/113 (4%)
Without LVA and not receiving OAC: 22/116 (19%)
With LVA and receiving OAC: 4/13 (31%)
With LVA and not receiving OAC: 5/10 (50%)
Highest recurrence: Patients with LVA who were not receiving OAC
Lowest recurrence: Patients without LVA who were receiving OAC
The key question:
If recurrence risk remains elevated across all groups, who can truly stop OAC after LVT resolution?
Stay tunned for Mayo LVT part 3″
Title: Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence
Authors: Kirsten M. Lipps, Hossam Elbenawi, Samuel Heller Jr., Robert D. McBane, Waldemar E. Wysokinski, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, David A. Liedl, Raymond C. Shields, Damon E. Houghton
Other posts featuring Hossam El Benawi on Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology